16 Nov 2021
Research presented at the recent Society for Endocrinology annual conference in Edinburgh, suggests that an AstraZeneca drug that inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 1 may improve wound healing in type 2 diabetes patients.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024